Dialogue Health Technologies Inc. (“Dialogue” or the “Company“) announced today that further to its recently completed initial public offering (the “Offering“) pursuant to which it sold an aggregate of 8,334,000 common shares of the Company at a price of $12.00 per share (the “Offering Price“), for total gross proceeds of approximately $100 million, the over-allotment option granted by certain shareholders of the Company (the “Selling Shareholders“) to the underwriters to purchase up to an additional 1,250,100 Common Shares at the Offering Price has been exercised in full.